BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12187372)

  • 1. [The efficacy of donepezil in Alzheimer's disease].
    Ito T; Yamadera H
    J Nippon Med Sch; 2002 Aug; 69(4):379-82. PubMed ID: 12187372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.
    Rogers SL; Doody RS; Mohs RC; Friedhoff LT
    Arch Intern Med; 1998 May; 158(9):1021-31. PubMed ID: 9588436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C; Oremus M; Shukla V; Momoli F; Demers L; Perrault A; Moride Y
    Clin Ther; 2002 Jun; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
    Winblad B; Kilander L; Eriksson S; Minthon L; Båtsman S; Wetterholm AL; Jansson-Blixt C; Haglund A;
    Lancet; 2006 Apr; 367(9516):1057-1065. PubMed ID: 16581404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
    Rogers SL
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.
    Onofrj M; Thomas A; Luciano AL; Iacono D; Di Rollo A; D'Andreamatteo G; Di Iorio A
    Clin Neuropharmacol; 2002; 25(4):207-15. PubMed ID: 12151908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donepezil for mild and moderate Alzheimer's disease.
    Birks JS; Melzer D; Beppu H
    Cochrane Database Syst Rev; 2000; (4):CD001190. PubMed ID: 11034704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
    Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
    Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients.
    Weiner MF; Martin-Cook K; Foster BM; Saine K; Fontaine CS; Svetlik DA
    J Clin Psychiatry; 2000 Jul; 61(7):487-92. PubMed ID: 10937606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil for mild and moderate Alzheimer's disease.
    Birks J S; Melzer D
    Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy of donepezil hydrochloride on the Apathy scale in Alzheimer's disease].
    Oguro H; Onoda K; Kobayashi S; Yamaguchi S
    Nihon Ronen Igakkai Zasshi; 2010; 47(5):481-2. PubMed ID: 21116094
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.
    Cummings JL; McRae T; Zhang R;
    Am J Geriatr Psychiatry; 2006 Jul; 14(7):605-12. PubMed ID: 16816014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J; Bergman H; Bullock R; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
    Courtney C; Farrell D; Gray R; Hills R; Lynch L; Sellwood E; Edwards S; Hardyman W; Raftery J; Crome P; Lendon C; Shaw H; Bentham P;
    Lancet; 2004 Jun; 363(9427):2105-15. PubMed ID: 15220031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil.
    Bryson HM; Benfield P
    Drugs Aging; 1997 Mar; 10(3):234-9; discussion 240-1. PubMed ID: 9108896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donepezil in patients with Alzheimer's disease previously untreated or treated with memantine or nootropic agents in Germany: an observational study.
    Klinger T; Ibach B; Schoenknecht P; Kamleiter M; Silver G; Schroeder J; Mielke R
    Curr Med Res Opin; 2005 May; 21(5):723-32. PubMed ID: 15969871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.
    Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A brief report on the efficacy of donepezil in pain management in Alzheimer's disease.
    Gharaei H; Shadlou H
    J Pain Palliat Care Pharmacother; 2014 Mar; 28(1):37-9. PubMed ID: 24456283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebo-controlled studies.
    Burns A; Yeates A; Akintade L; Del Valle M; Zhang RY; Schwam EM; Perdomo CA
    Drugs Aging; 2008; 25(8):707-14. PubMed ID: 18665662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.